Nutrien Ltd — 7.0/10 — $75.47
Gate result: All three gates PASS. No scoring cap applied. Oligopoly position is textbook; FCF is positive and growing; management has a clear track record of execution.
| Dimension | Score | Weight | Weighted |
|---|---|---|---|
| Financial Strength | 7 | 25% | 1.75 |
| Thematic / Structural Tailwinds | 8 | 25% | 2.00 |
| Management Quality | 7 | 20% | 1.40 |
| Investor Sentiment | 6 | 15% | 0.90 |
| Concerns, Catalysts & Risks | 6 | 15% | 0.90 |
| Composite | 100% | 6.95 |
Nutrien Ltd is the world largest provider of crop inputs and services. Formed in 2018 from the merger of PotashCorp and Agrium, the company operates through four segments: Retail (ag retail network of ~2,000 locations, $1.74B EBITDA), Potash (world largest producer at 14.25MT in 2025), Nitrogen (major North American producer at 10.9MT), and Phosphate.
The investment case rests on three pillars: (1) Potash oligopoly -- NTR controls ~20-25% of global potash supply through its 6-mine Saskatchewan network. Top 3-4 producers control >70% of global supply. Controllable cash cost of $58/tonne vs benchmark $355-375/tonne yields >75% EBITDA margins. Brownfield expansion at $150-200/tonne vs $3B+ for greenfield creates enormous barriers to entry. (2) Vertical integration -- NTR is the only company globally combining world largest potash production with world largest ag retail distribution. This provides unique demand visibility and counter-cyclical earnings stability. (3) Capital discipline -- $200M cost savings delivered 1 year ahead of schedule, CapEx below guidance, net debt/EBITDA improving toward 1.5x target, 8th consecutive dividend increase.
The concern is valuation timing. The stock has rallied ~65% from its 2024 lows (~$46) to $75.47. Consensus 12-month target is $74.18, essentially flat. The easy re-rating is done. At 7.8x EV/EBITDA and 14.2x forward P/E, NTR is fairly valued -- not expensive but not a screaming buy either. Best entry on pullback to $60-65 (implying ~8% FCF yield and 6.5x EV/EBITDA).
| Price (USD) | $75.47 | FY2025 Revenue | $26.9B (+3.5% YoY) |
| Market Cap | $36.3B | Adj. EBITDA | $6.05B (+13% YoY) |
| Forward P/E | 14.2x | Free Cash Flow | $2.0B (5.5% yield) |
| EV/EBITDA | ~7.8x | Net Debt/EBITDA | 1.8x (target 1.5x) |
| 52-Week Range | $45.78 - $85.36 | Dividend Yield | 2.9% (8th consecutive increase) |
| CEO | Ken Seitz (since 2023) | Potash Cash Cost | $58/tonne (vs $355-375 benchmark) |
Nutrien receives a composite score of 7.0/10, reflecting strong thematic positioning (8) and solid financial strength plus management execution (7/7), balanced by neutral sentiment and moderate risk profiles (6/6). All three quality gates pass convincingly.
Bull case (~$95-110, +26-46%): Potash supply remains tight through 2026-2027; prices firm to $400+/tonne. Phosphate divestiture unlocks $500M-1B, accelerating deleveraging and buybacks. Retail EBITDA hits $2B+ as proprietary products and cost savings compound. FCF/share growth of 10%+ annually drives re-rating to 9-10x EV/EBITDA.
Base case (~$75-85, flat to +13%): Potash prices stable at $350-375; volumes grow at trend to 14.5MT. Adj. EBITDA ~$6.0-6.5B; FCF ~$2.0-2.5B. Gradual deleveraging to 1.5x by 2027. Total return: 2.9% dividend + 3-5% buyback yield + modest multiple expansion = 8-12% annualized.
Bear case (~$45-55, -27% to -41%): Belarusian supply normalizes, potash crashes to $250/tonne. Ag downturn delays fertilizer purchasing. Brazil reverts to losses; phosphate review yields no buyer. Adj. EBITDA drops to $4.0B; net debt/EBITDA spikes to 2.8x; stock retests $50.
Bottom line: NTR is a high-quality commodity business with genuine structural advantages. At current levels (~$75), the stock is fairly valued -- not a screaming buy but a solid portfolio holding for exposure to the food security / agricultural intensification theme. The best entry point would be on a pullback to $60-65 (implying ~8% FCF yield and 6.5x EV/EBITDA). Key catalysts to monitor: phosphate review outcome (H1 2026), potash pricing dynamics, and Q1 2026 working capital unwind.
Key catalysts and monitoring points:
- Phosphate strategic review (H1 2026): Management is actively evaluating alternatives for the phosphate segment. A divestiture could unlock $500M-1B of capital for deleveraging and buybacks. This is the single most important near-term catalyst.
- Potash pricing dynamics: Current benchmark $355-375/tonne. A $20/tonne move impacts EPS by ~$0.30-0.40. Monitor Belarusian sanctions/logistics and Laos supply ramp.
- Q1 2026 earnings: Watch for working capital unwind (typically strong Q1 cash flow), potash volume trajectory toward 14.1-14.8MT guidance, and retail margin commentary.
- Brazil retail outcome: Management acknowledged reviewing alternatives for each component of Brazilian retail. An exit would remove a drag and simplify the story.
- Retail proprietary product growth: Targeting high-single-digit annual gross margin growth. 26 new products launching in 2026. This is the key driver of retail EBITDA expansion toward $2B+.
- Nitrogen reliability: Ammonia operating rate improved from 87% to 94%. Sustained improvement supports nitrogen EBITDA without incremental capital.
- Leverage trajectory: Net debt/EBITDA at 1.8x, targeting 1.5x mid-cycle. Progress here opens capacity for accelerated buybacks or dividend growth.
For the full analysis, see the Business Model, Financials, Thematics, Management, and Valuation pages.